☆ 4.5 Review

Human papillomavirus (HPV) vaccination: a call for action in Italy

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Oncology

Monitoring the activities of Italian colposcopy clinics before and during the COVID-19 pandemic

Giovanni Delli Carpini et al.

Summary: This study evaluates the impact of healthcare reorganization during the COVID-19 pandemic on Italian colposcopy clinic activities, specifically focusing on cervical excision procedures, follow-ups for conservative management of low-grade lesions, and follow-ups post cervical excision. The results show a reduction in the number of cervical excisions by 8.8% during the pandemic period compared to pre-pandemic. There were also significant reductions in the follow-ups for low-grade lesion management and follow-up appointments after cervical excision.

JOURNAL OF GYNECOLOGIC ONCOLOGY (2023)

添加到收藏夹

Review Oncology

Cervical cancer, geographical inequalities, prevention and barriers in resource depleted countries

Anna Bogdanova et al.

Summary: Cervical cancer is a global issue, with most cases attributed to HPV infection. Developing countries face barriers such as inaccessibility to expensive vaccines and limited screening programs and trained healthcare teams. Developing primary and secondary prevention programs and addressing barriers in low-income countries can significantly reduce the burden of cervical cancer.

ONCOLOGY LETTERS (2022)

添加到收藏夹

Article Oncology

Immunogenicity and safety of a bivalent, adjuvant system 04-adjuvanted human papillomavirus vaccine in healthy female volunteers aged 15-25: a randomized, double-blind, phase III, noninferiority clinical trial

Seyyedeh Maryam Afshani et al.

Summary: This study compared the immunogenicity and safety of Papilloguard and Cervarix vaccines, finding that both vaccines were effective in inducing an immune response with similar rates of seroconversion and tolerable adverse events.

EUROPEAN JOURNAL OF CANCER PREVENTION (2022)

添加到收藏夹

Article Immunology

The cost-effectiveness of human papillomavirus vaccination in the Philippines

Cecilia L. Llave et al.

Summary: Cervical cancer is the second most common cancer among women in the Philippines. HPV vaccines provide protection against the most common cancer-causing HPV types. This study analyzed the cost-effectiveness of different HPV vaccine products and found that some vaccines were cost-effective from both government and societal perspectives, while GARDASIL (R) 9 was not cost-effective under any scenario.

VACCINE (2022)

添加到收藏夹

Article Oncology

Precancerous cervical lesions caused by non-vaccine- preventable HPV types after vaccination with the bivalent AS04-adjuvanted HPV vaccine: an analysis of the long-term follow-up study from the randomised Costa Rica HPV Vaccine Trial

Jaimie Z. Shing et al.

Summary: A long-term follow-up study was conducted to evaluate the efficacy of HPV vaccination against cervical intraepithelial neoplasia caused by non-preventable HPV types. The study found that clinical unmasking could attenuate the long-term effectiveness of HPV vaccination in reducing high-grade diseases. However, the net benefit of vaccination for cervical cancer prevention is still considerable.

LANCET ONCOLOGY (2022)

添加到收藏夹

Article Biotechnology & Applied Microbiology

Long-term effectiveness of the nine-valent human papillomavirus vaccine in Scandinavian women: interim analysis after 8 years of follow-up

Susanne K. Kjaer et al.

Summary: The long-term follow-up study of the nine-valent human papillomavirus vaccine in young women aged 16-26 showed continued effectiveness above 90% for up to 14 years, with no new cases observed. This indicates that the vaccine provides significant protection through at least 6 years, and possibly up to 8 years.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2021)

添加到收藏夹

Article Medicine, General & Internal

The effects of the national HPV vaccination programme in England, UK, on cervical cancer and grade 3 cervical intraepithelial neoplasia incidence: a register-based observational study

Milena Falcaro et al.

Summary: A study in England found a significant reduction in cervical cancer and CIN3 incidence in young women after the introduction of the HPV immunisation programme, especially in those vaccinated at age 12-13. The programme has successfully almost eliminated cervical cancer in women born since September 1, 1995.

LANCET (2021)

添加到收藏夹

Article Immunology

Immunogenicity and safety of a nine-valent human papillomavirus vaccine in women 27-45 years of age compared to women 16-26 years of age: An open-label phase 3 study

Elmar A. Joura et al.

Summary: The study demonstrated the immunogenicity and safety of the nine-valent human papillomavirus vaccine in women aged 27-45, showing non-inferior antibody titers and seroconversion rates compared to women aged 16-26. The vaccine had a strong immune response for all HPV types and a similar safety profile across different age groups.

VACCINE (2021)

添加到收藏夹

Article Immunology

Vaccine exposure during pregnancy among privately and publicly insured women in the United States, 2016-2018

Keran Moll et al.

Summary: The study found that the use of recommended vaccines during pregnancy was low among privately and Medicaid-insured women, and inadvertent exposure to contraindicated vaccines during pregnancy was rare.

VACCINE (2021)

添加到收藏夹

Article Immunology

Impact of reduced human papillomavirus vaccination coverage rates due to COVID-19 in the United States: A model based analysis

Vincent Daniels et al.

Summary: The COVID-19 pandemic has led to a significant decrease in utilization of preventative health care, including vaccines. A simulation model predicts additional cases of genital warts, cervical cancer, and other diseases over the next 100 years compared to pre-COVID times, highlighting the importance of efforts to recover HPV vaccination rates.

VACCINE (2021)

添加到收藏夹

Article Immunology

HPV and Cytology Testing in Women Undergoing 9-Valent HPV Opportunistic Vaccination: A Single-Cohort Follow Up Study

Rosa De Vincenzo et al.

Summary: This study evaluated the effect of 9-valent HPV vaccination on HPV and cytological test results in adult women. The results showed a significant reduction in clearance time for HPV HR+ and Pap positivity in women who received the third dose of the vaccine.

VACCINES (2021)

添加到收藏夹

Article Oncology

Risk of cervical intraepithelial neoplasia grade 2 or worse after conization in relation to HPV vaccination status

Freja L. Sand et al.

INTERNATIONAL JOURNAL OF CANCER (2020)

添加到收藏夹

Article Immunology

Human Papillomavirus Vaccine Effectiveness Against HPV Infection: Evaluation of One, Two, and Three Doses

Lauri E. Markowitz et al.

JOURNAL OF INFECTIOUS DISEASES (2020)

添加到收藏夹

Article Oncology

Efficacy of the AS04-Adjuvanted HPV16/18 Vaccine: Pooled Analysis of the Costa Rica Vaccine and PATRICIA Randomized Controlled Trials

Joseph E. Tota et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2020)

添加到收藏夹

Article Oncology

Durability of Cross-Protection by Different Schedules of the Bivalent HPV Vaccine: The CVT Trial

Sabrina H. Tsang et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2020)

添加到收藏夹

Article Immunology

Efficacy of HPV Vaccination in Women Receiving LEEP for Cervical Dysplasia: A Single Institution's Experience

Marco Petrillo et al.

VACCINES (2020)

添加到收藏夹

Article Oncology

Recurrence rate after loop electrosurgical excision procedure (LEEP) and laser Conization: A 5-year follow-up study

Giorgio Bogani et al.

GYNECOLOGIC ONCOLOGY (2020)

添加到收藏夹

Article Medicine, General & Internal

HPV Vaccination and the Risk of Invasive Cervical Cancer

Jiayao Lei et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

添加到收藏夹

Article Public, Environmental & Occupational Health

Improvement of Parent's awareness, knowledge, perception, and acceptability of human papillomavirus vaccination after a structured-educational intervention

Mei Neni Sitaresmi et al.

BMC PUBLIC HEALTH (2020)

添加到收藏夹

Article Oncology

Efficacy of the bivalent HPV vaccine against HPV 16/18-associated precancer: long-term follow-up results from the Costa Rica Vaccine Trial

Carolina Porras et al.

LANCET ONCOLOGY (2020)

添加到收藏夹

Article Immunology

Assessing the Long-Term Role of Vaccination against HPV after Loop Electrosurgical Excision Procedure (LEEP): A Propensity-Score Matched Comparison

Giorgio Bogani et al.

VACCINES (2020)

添加到收藏夹

Article Virology

Is one dose of human papillomavirus vaccine as effective as three?: A national cohort analysis

Julia M. L. Brotherton et al.

PAPILLOMAVIRUS RESEARCH (2019)

添加到收藏夹

Article Oncology

SPERANZA project: HPV vaccination after treatment for CIN2+

Alessandro Ghelardi et al.

GYNECOLOGIC ONCOLOGY (2018)

添加到收藏夹

Article Medicine, General & Internal

Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16-26 years: a randomised, double-blind trial

Warner K. Huh et al.

LANCET (2017)

添加到收藏夹

Article Infectious Diseases

Recurrence of Human Papillomavirus External Genital Wart Infection Among High-Risk Adults in Montreal, Canada

Rejean Thomas et al.

SEXUALLY TRANSMITTED DISEASES (2017)

添加到收藏夹

Article Oncology

Prior human papillomavirus-16/18 AS04-adjuvanted vaccination prevents recurrent high grade cervical intraepithelial neoplasia after definitive surgical therapy: Post-hoc analysis from a randomized controlled trial

Suzanne M. Garland et al.

INTERNATIONAL JOURNAL OF CANCER (2016)

添加到收藏夹

Article Medicine, General & Internal

A 9-Valent HPV Vaccine against Infection and Intraepithelial Neoplasia in Women

E. A. Joura et al.

NEW ENGLAND JOURNAL OF MEDICINE (2015)

添加到收藏夹

Article Pediatrics

Coadministration of a 9-Valent Human Papillomavirus Vaccine With Meningococcal and Tdap Vaccines

Andrea Schilling et al.

PEDIATRICS (2015)

添加到收藏夹

Article Medicine, General & Internal

Effect of bivalent human papillomavirus vaccination on pregnancy outcomes: long term observational follow-up in the Costa Rica HPV Vaccine Trial

Orestis A. Panagiotou et al.

BMJ-BRITISH MEDICAL JOURNAL (2015)

添加到收藏夹

Article Medicine, General & Internal

Effect of bivalent human papillomavirus vaccination on pregnancy outcomes: long term observational follow-up in the Costa Rica HPV Vaccine Trial

Orestis A. Panagiotou et al.

BMJ-BRITISH MEDICAL JOURNAL (2015)

添加到收藏夹

Review Oncology

The incidence of human papillomavirus infection following treatment for cervical neoplasia: A systematic review

Anne F. Rositch et al.

GYNECOLOGIC ONCOLOGY (2014)

添加到收藏夹

Article Medicine, General & Internal

Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 4-year interim follow-up of the phase 3, double-blind, randomised controlled VIVIANE study

S. Rachel Skinner et al.

LANCET (2014)

添加到收藏夹

Article Oncology

Is vaccination with quadrivalent HPV vaccine after loop electrosurgical excision procedure effective in preventing recurrence in patients with high-grade cervical intraepithelial neoplasia (CIN2-3)?

Woo Dae Kang et al.

GYNECOLOGIC ONCOLOGY (2013)

添加到收藏夹

Article Immunology

Efficacy of the HPV-16/18 AS04-Adjuvanted Vaccine Against Low-Risk HPV Types (PATRICIA Randomized Trial): An Unexpected Observation

Anne Szarewski et al.

JOURNAL OF INFECTIOUS DISEASES (2013)

添加到收藏夹

Article Medicine, General & Internal

Effect of the human papillomavirus (HPV) quadrivalent vaccine in a subgroup of women with cervical and vulvar disease: retrospective pooled analysis of trial data

Elmar A. Joura et al.

BMJ-BRITISH MEDICAL JOURNAL (2012)

添加到收藏夹

Article Medicine, General & Internal

Efficacy of Quadrivalent HPV Vaccine against HPV Infection and Disease in Males

Anna R. Giuliano et al.

NEW ENGLAND JOURNAL OF MEDICINE (2011)

添加到收藏夹

Article Medicine, General & Internal

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women

J. Paovonen et al.

LANCET (2009)

添加到收藏夹

Article Obstetrics & Gynecology

Pregnancy and Infant Outcomes in the Clinical Trials of a Human Papillomavirus Type 6/11/16/18 Vaccine A Combined Analysis of Five Randomized Controlled Trials

Suzanne M. Garland et al.

OBSTETRICS AND GYNECOLOGY (2009)

添加到收藏夹

Article Medicine, General & Internal

Effect of human papillomavirus 16/18 L1 viruslike particle vaccine among young women with preexisting infection - A randomized trial

Allan Hildesheim et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)

添加到收藏夹

Article Medicine, General & Internal

Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases

Suzanne M. Garland et al.

NEW ENGLAND JOURNAL OF MEDICINE (2007)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.